Search results for "Molecular Docking Simulation"

showing 10 items of 151 documents

Reliability of Virtual Screening Methods in Prediction of PDE4Binhibitor Activity

2015

Identification of active ligands using computational methods is a challenging task. For example, molecular docking, pharmacophore modeling, and three dimensional quantitative structure-activity relationship models (3D-QSAR) are widely used methods to identify novel small molecules. However, all these methods have, in addition to advantages, also significant pitfalls. The aim of this study was to compare some commonly used computational methods to estimate their ability to separate highly active PDE4B-inhibitors from less active and inactive ones. Here, 152 molecules with pIC 50 -range of 3.4-10.5, originating from six original studies were used. High correlation coefficients by using dockin…

Computer scienceQuantitative Structure-Activity RelationshipMultiple methodsLigandsComputers MolecularDrug DiscoveryProtein Interaction MappingHumansSimulationPharmacological Phenomenathree-dimensional quantitative structure-activity relationshipVirtual screeningbusiness.industryta1182Pattern recognitionmolecular dockingmolecular mechanics-generalized born-surface areavirtual screeningCyclic Nucleotide Phosphodiesterases Type 4Molecular Docking SimulationDocking (molecular)pharmacophore modelingArtificial intelligencePhosphodiesterase 4 InhibitorsPharmacophorebusinessphosphodiesteraseCurrent Drug Discovery Technologies
researchProduct

Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening

2021

During almost all 2020, coronavirus disease 2019 (COVID-19) pandemic has constituted the major risk for the worldwide health and economy, propelling unprecedented efforts to discover drugs for its prevention and cure. At the end of the year, these efforts have culminated with the approval of vaccines by the American Food and Drug Administration (FDA) and the European Medicines Agency (EMA) giving new hope for the future. On the other hand, clinical data underscore the urgent need for effective drugs to treat COVID-19 patients. In this work, we embarked on a virtual screening campaign against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Mpro chymotrypsin-like cysteine pro…

Coronavirus disease 2019 (COVID-19)General Chemical Engineeringmedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)In silicoComputational biologyLibrary and Information Sciences01 natural sciencesMolecular Docking SimulationAntiviral AgentsArticleDocking (dog)0103 physical sciencesmedicineHumansProtease InhibitorsPandemicsVirtual screeningProtease010304 chemical physicsbusiness.industrySARS-CoV-2COVID-19General Chemistry0104 chemical sciencesComputer Science ApplicationsMolecular Docking Simulation010404 medicinal & biomolecular chemistryTarget proteinbusinessJournal of Chemical Information and Modeling
researchProduct

Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na(+)/K(+)-ATPase.

2015

Cardiotonic steroids have long been in clinical use for treatment of heart failure and are now emerging as promising agents in various diseases, especially cancer. Their main target is Na(+)/K(+)-ATPase, a membrane protein involved in cellular ion homeostasis. Na(+)/K(+)-ATPase has been implicated in cancer biology by affecting several cellular events and signaling pathways in both sensitive and drug-resistant cancer cells. Hence, we investigated the cytotoxic activities of 66 cardiotonic steroids and cardiotonic steroid derivatives in sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells. Data were then subjected to quantitative structure-activity relationship analysis (QSA…

DigoxinCell SurvivalEndocrinology Diabetes and MetabolismClinical BiochemistryPrimary Cell CultureGene ExpressionQuantitative Structure-Activity RelationshipAntineoplastic AgentsBiologyPharmacologyBiochemistryCardiac GlycosidesEndocrinologyCellular ion homeostasisCell Line TumorCytotoxic T cellHumansNa+/K+-ATPaseCytotoxicityMolecular BiologyCell BiologyMolecular biologyDrug Resistance MultipleBlotBufanolidesMolecular Docking SimulationVerapamilCell cultureDoxorubicinDrug Resistance NeoplasmCancer cellLeukocytes MononuclearMolecular MedicineSignal transductionSodium-Potassium-Exchanging ATPaseSignal TransductionThe Journal of steroid biochemistry and molecular biology
researchProduct

Studies on a new potential dopaminergic agent: in vitro BBB permeability, in vivo behavioural effects and molecular docking evaluation.

2015

2-Amino-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-3-phenyl-propionamide (DA-PHEN) has been previously synthesized to obtain a potential prodrug capable of release dopamine (DA) into CNS. However, DA-PHEN could act per se as a dopaminergic drug. In this study, the permeability transport (Pe), obtained by parallel artificial permeability assay (PAMPA), indicated a low passive transcellular transport (Pe = 0.32 ± 0.01 × 10(-6 )cm/s). Using the Caco-2 cell system, the Papp AP-BL in absorptive direction (3.36 ± 0.02 × 10(-5 )cm/s) was significantly higher than the Papp BL-AP in secretive direction (1.75 ± 0.07 × 10(-5 )cm/s), suggesting a polarized transport. The efflux ratio (Papp AP-BL/Papp BL-AP = 0…

DopaminePhenylalanineDopamine AgentsPharmaceutical ScienceMorris water navigation taskPharmacologyBiologyCognitive flexibilityPermeabilityIn vivoDopamineSettore BIO/10 - BiochimicaPAMPA-BBBmedicineHumansIn vivo behavioural effectDopaminergicProdrugSettore CHIM/08 - Chimica FarmaceuticaMolecular Docking SimulationSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBlood-Brain BarrierParacellular transportMolecular docking D1-receptorSettore BIO/14 - FarmacologiaEffluxCaco-2 bidirectional assayCaco-2 CellsTranscytosisBehavioural despair testmedicine.drugJournal of drug targeting
researchProduct

Synthesis of N-acyl Derivatives of Aminocombretastatin A-4 and Study of their Interaction with Tubulin and Downregulation of c-Myc.

2021

11 p.-9 fig.-4 tab.

Down-RegulationAntineoplastic AgentsMicrotubule dynamicsStructure-Activity RelationshipDownregulation and upregulationMicrotubuleTubulinCell Line TumorDrug DiscoveryHumansMTT assayAminocombretastatin A-4Cell ProliferationbiologyChemistryCell growthIn vitroTubulin ModulatorsMolecular Docking SimulationTubulinc-MycBiochemistryCell cultureDocking (molecular)biology.proteinDrug Screening Assays AntitumorAnti-proliferative activityAnti-mitoticMedicinal chemistry (Shariqah (United Arab Emirates))
researchProduct

Protocol for rational design of covalently interacting inhibitors.

2014

The inhibition potencies of covalent inhibitors mainly result from the formation of a covalent bond to the enzyme during the inhibition mechanism. This class of inhibitors has essentially been ignored in previous target-directed drug discovery projects because of concerns about possible side effects. However, their advantages, such as higher binding energies and longer drug-target residence times moved them into the focus of recent investigations. While the rational design of non-covalent inhibitors became standard the corresponding design of covalent inhibitors is still in its early stages. Potent covalent inhibitors can be retrieved from large compound libraries by covalent docking approa…

Drug discoveryChemistryRational designHybrid approachCombinatorial chemistryAtomic and Molecular Physics and OpticsEnzymesQM/MMMolecular Docking SimulationNitrophenolsHIV ProteaseDocking (molecular)Covalent bondCatalytic DomainDrug DesignEpoxy CompoundsHumansQuantum TheoryPhysical and Theoretical ChemistryBinding siteEnzyme InhibitorsChemphyschem : a European journal of chemical physics and physical chemistry
researchProduct

Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid wortmannin against multidrug-resistant tumor cells

2014

Wortmannin is a cytotoxic compound derived from the endophytic fungi Fusarium oxysporum, Penicillium wortmannii and Penicillium funiculosum that occurs in many plants, including medicinal herbs. The rationale to develop novel anticancer drugs is the frequent development of tumor resistance to the existing antineoplasic agents. Therefore, it is mandatory to analyze resistance mechanisms of novel drug candidates such as wortmannin as well to bring effective drugs into the clinic that have the potential to bypass or overcome resistance to established drugs and to substantially increase life span of cancer patients. In the present project, we found that P-glycoprotein-overexpressing tumor cells…

DrugATP Binding Cassette Transporter Subfamily BClass I Phosphatidylinositol 3-Kinasesmedia_common.quotation_subjectPharmaceutical ScienceAntineoplastic AgentsATP-binding cassette transporterDrug resistancePharmacologyBiologyWortmanninPhosphatidylinositol 3-Kinaseschemistry.chemical_compoundCell Line TumorDrug DiscoveryCluster AnalysisHumansCytotoxicityProtein kinase BPI3K/AKT/mTOR pathwayOligonucleotide Array Sequence Analysismedia_commonPharmacologyDrug Resistance MultipleAndrostadienesMolecular Docking SimulationMultiple drug resistanceComplementary and alternative medicinechemistryDrug Resistance NeoplasmPharmacogeneticsMolecular MedicineWortmanninSignal TransductionPhytomedicine
researchProduct

A high-quality homology model for the human dopamine transporter validated for drug design purposes.

2018

The human dopamine transporter (hDAT) plays many vital functions within the central nervous system and is thus targeted by many pharmaceutical agents. Dopamine-related therapies are in current development for individuals with dopamine-related disorders including depression, Parkinson's disease, and psychostimulant addictions such as cocaine abuse. Yet, most efforts to develop new dopamine therapies are within costly structure-activity relationship studies. Through structure-based drug design techniques, the binding site of hDAT can be utilized to develop novel selective and potent dopamine therapies at reduced costs. However, no structural models of hDAT specifically validated for rational …

DrugComputer sciencemedia_common.quotation_subjectDrug designComputational biologyNortriptyline01 natural sciencesBiochemistryInhibitory Concentration 50DopamineDrug DiscoverymedicineAnimalsDrosophila ProteinsHumansHomology modelingmedia_commonDopamine transporterPharmacologyDopamine Plasma Membrane Transport ProteinsBinding Sitesbiology010405 organic chemistryAddictionOrganic Chemistry0104 chemical sciencesProtein Structure TertiaryMolecular Docking Simulation010404 medicinal & biomolecular chemistryDrug Designbiology.proteinMolecular MedicineDrosophilaCocaine abusemedicine.drugChemical biologydrug design
researchProduct

Microscopic interactions between ivermectin and key human and viral proteins involved in SARS-CoV-2 infection

2021

The identification of chemical compounds able to bind specific sites of the human/viral proteins involved in the SARS-CoV-2 infection cycle is a prerequisite to design effective antiviral drugs. Here we conduct a molecular dynamics study with the aim to assess the interactions of ivermectin, an antiparasitic drug with broad-spectrum antiviral activity, with the human Angiotensin-Converting Enzyme 2 (ACE2), the viral 3CLpro and PLpro proteases, and the viral SARS Unique Domain (SUD). The drug/target interactions have been characterized in silico by describing the nature of the non-covalent interactions found and by measuring the extent of their time duration along the MD simulation. Results …

DrugProteasesIn silicomedia_common.quotation_subjectProtein domainCoronavirus Papain-Like ProteasesGeneral Physics and AstronomyPlasma protein bindingBiologyAntiviral AgentsivermectinProtein DomainsMolecular dynamics simulationHumansPhysical and Theoretical ChemistryBinding siteCoronavirus 3C Proteasesmedia_commonchemistry.chemical_classificationSARS Unique DomainBinding SitesSARS-CoV-2SARS-CoV-2 infectionRNAHydrogen BondingVirologyG-QuadruplexesMolecular Docking SimulationEnzymechemistrySettore CHIM/03 - Chimica Generale E InorganicaRNAAngiotensin-Converting Enzyme 2Hydrophobic and Hydrophilic InteractionsProtein BindingPhysical Chemistry Chemical Physics
researchProduct

Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum

2012

Malaria causes millions of death cases per year. Since Plasmodium falciparum rapidly develops drug resistance, it is of high importance to investigate potential drug targets which may lead to novel rational therapy approaches. Here we report on the interaction of translationally controlled tumor protein of P. falciparum (PfTCTP) with the anti-malarial drug artemisinin. Furthermore, we investigated the crystal structure of PfTCTP. Using mass spectrometry, bioinformatic approaches and surface plasmon resonance spectroscopy, we identified novel binding sites of artemisinin which are in direct neighborhood to amino acids 19-46, 108-134 and 140-163. The regions covered by these residues are know…

Drugmedia_common.quotation_subjectPlasmodium falciparumProtozoan ProteinsDrug resistanceBiologyCrystallography X-RayBiochemistryAntimalarialsparasitic diseasesTranslationally-controlled tumor proteinBiomarkers TumormedicineHumansComputer SimulationBinding siteArtemisininmedia_commonPharmacologychemistry.chemical_classificationBinding SitesMolecular StructureTumor Protein Translationally-Controlled 1Plasmodium falciparumSurface Plasmon Resonancebiology.organism_classificationArtemisininsRecombinant ProteinsAmino acidMolecular Docking SimulationchemistryBiochemistryFunction (biology)Protein Bindingmedicine.drugBiochemical Pharmacology
researchProduct